• BX Home
  • Abbott Laboratories: News [Page 30]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

ABBOTT LABORATORIES

Abbott Laboratories is a diversified pharmaceuticals healthcare company headquartered in Abbot Part, Illinois. It operates in four segments: pharmaceutical products; diagnostic products; nutritional products; and vascular products. In 1985, Abbott develop dthe first HIV screen test. The company’s drug portfolio includes Humira, Synthroid, and Dupakote; and its most popular nutritional product is Ensure.

Abbott Laboratories is part of Business Exchange, suggested by Maki Yamasaki. This topic contains 921 news and 191 blog items. Read updated news, blogs, and resources about Abbott Laboratories. Find user-submitted articles and reactions on Abbott Laboratories from like-minded professionals.

News

Please add new articles to this topic

What will the data show today?more

shares surged 41.6 percent in extended trade on Monday after the company agreed to be acquired by Abbott Laboratories...

FDA Warns Abbott Subsidiary Over Manufacturing Violationsmore

WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration has warned an Abbott Laboratories (ABT) subsidiary for...

Celgene psoriasis drug shows promise in trialmore

is delivered by injection, Apremilast is an oral drug. Other TNF inhibitors include Humira, which is made by Abbott...

Abbott Labs to buy Starlims Tech for $123 Mlnmore

LOS ANGELES (MarketWatch) -- Abbott Laboratories said late Monday it has reached an agreement to acquire Starlims...

Claims in drug advertising are attracting new scrutinymore

Earvin 'Magic' Johnson describing his 'normal life' while taking the HIV drug Kaletra. The FDA wrote to Illinois-based...

Despite Numbers, Package-Goods Players Are Ramping Up Online Spendmore

do and not something they allow others to do alone.' For Bridge, whose clients include P&G, ConAgra Foods, Abbott...

S.E.C. Said to Eye Insider Trading in Healthcare Dealsmore

was connected to the recent subpoenas. The S.E.C. also is looking at other pharmaceutical deals including Abbott...

Abbott's Strength Comes On Two Major Productsmore

By PATRICK CAIN, INVESTOR'S BUSINESS DAILYPosted 12/07/2009 06:27 PM ET Featured Stocks Abbott Laboratories * Top-Rated...

Deal Economy 2010: Strategic Mmore

Elias Mendoza of IBM Corp. (NYSE:IBM), Sean Murphy of Abbott Laboratories (NYSE:ABT) and Duncan O'Brien of General...

Research and Markets: Philippines Pharmaceuticals and Healthcare Repor...more

Demographic Data Companies Mentioned: * GlaxoSmithKline Philippines * Pfizer * Novartis * Merck & Co *...

Tests of Abbott's drug-coated stents show positive resultsmore

Drugmaker hopes to expand trials of bioabsorbable stents to include more patients X Text Size Abbott Laboratories'...

Consumer advocate asks FDA to ban weight loss pillmore

stroke and death. A letter Thursday from Public Citizen calls on the Food and Drug Administration to pull Abbott...

Enfamil Maker Loses False-Advertising Suit Against PBMmore

which took the matter to the Federal Trade Commission earlier this year for review. Other competitors, such as Abbott...

Fitch: Economic Pressure & Event Risk Will Drive U.S. Healthcare's...more

Community Health Systems should be the most active. Fitch currently rates the U.S. healthcare sector as follows: Abbott...

Merck Makes a Mark on Good Cholesterolmore

And that happened before the presentation of clinical-trial results at an American Heart Association meeting earlier...

Abbott settles TriCor suitmore

Abbott Laboratories has settled U.S. patent litigation over its blockbuster cholesterol pill TriCor in a deal that...

Abbott, Teva Deal to Delay Generic Salesmore

Abbott Laboratories said Monday that it has reached a deal with Teva Pharmaceuticals that postpones the sale of a...

Abbott reaches generics deal with Teva on TriCormore

Abbott Laboratories has settled U.S. patent litigation over its blockbuster cholesterol pill TriCor in a deal that...

UPDATE: Abbott Reaches Generics Deal With Teva On TriCormore

background in paragraphs 2-6 and comments from Abbott and J.P. Morgan, updates stock prices) DOW JONES NEWSWIRES Abbott...

Abbott settles Tricor patent row with Tevamore

mg dose * Abbott shares up 0.2 pct, Teva down 0.3 pct NEW YORK (Reuters) - Abbott Laboratories Inc said Monday it...

UPDATE 1-Abbott settles Tricor patent row with Tevamore

* Abbott shares up 0.2 pct, Teva down 0.3 pct NEW YORK, Nov 30 (Reuters) - Abbott Laboratories Inc (ABT.

Top 100 Global Advertisers Heap Their Spending Abroadmore

bulk of their own ad spending in the U.S. Eli Lilly & Co., Merck & Co. and Abbott Laboratories all spend more...

Shop for Dividends imore

likes many big drug companies, seeing strong cash flow and solid balance sheets at the likes of Merck, Abbott...

Peter Brimelow: An extra Thanksgiving for Linde Equity Reportmore

still rates it as "undervalued," which the HFD also interprets as a buy. In contrast, Linde rated Abbott...

An extra Thanksgiving for Linde Equity Reportmore

and still rates it as 'undervalued,' which the HFD also interprets as a buy. In contrast, Linde rated Abbott...

Top Sources: Abbott Laboratories

  • BusinessWeek
  • MarketWatch
  • Reuters
  • Chicago Tribune
  • thedeal.com
  • chicagobusiness.com
  • CNN Money
  • TheStreet.com
  • CNBC
  • innovationexcellence.com

Most Active Users in this Topic

see all contributors in Abbott Laboratories

Featured White Papers

Post a Job

Jobs in this Topic

Director, Laboratory Operations Abbott Laboratories | Irvine, CA
Posted: Jan 30
Sr. Director Regulatory Affairs Abbott Laboratories | Carlsbad, CA
Posted: May 20
WAREHOUSE SUPERVISOR Abbott Laboratories | Milpitas, CA
Posted: May 2
Project Manager, Service Abbott Laboratories | Santa Ana, CA
Posted: May 20
Sr Product Manager, US Endovascular Abbott Laboratories | Santa Clara, CA
Posted: May 13

Report comment contains invalid characters. ()
cancel
Search Cancel